ORIGINAL RESEARCH
Eitan Novogrodsky, MD; Linda B Haramati, MD, MS; Geraldine M Villasana-Gomez, MD; Jessica Goldman, MD; Cyril Rosenfeld, MD; Jessica K Rosenblum, MD; James W Sayre, PhD; Anne C Hoyt, MD; Jonathan G Goldin, MD, PhD; Hannah S Milch, MD
Corresponding Author: Eitan Novogrodsky, MD; Department of Radiology - Montefiore Medical Center; Albert Einstein College of Medicine
Email: eitannovo@gmail.com
DOI: 10.3122/jabfm.2022.220423R1
Keywords: Breast Cancer, Cancer, Early Detection of Cancer, Health Promotion, Lung Cancer, Mammography, Patient Adherence, Preventive Medicine, Screening
Dates: Submitted: 12-14-2022; Revised: 03-05-2023; Accepted: 03-13-2023
AHEAD OF PRINT: |HTML| |PDF| FINAL PUBLICATION: |HTML| |PDF|
OBJECTIVE: To determine lung cancer screening eligibility, knowledge, and interest and to quantify the effect of the expanded 2021 lung cancer screening eligibility criteria among women presenting for screening mammography, a group with demonstrable interest in cancer screening.
METHODS: A single-page survey was distributed to patients presenting for screening mammography, from January-March 2020 and June 2020-January 2021, at two academic medical centers on the East and West Coasts. The population served by the East Coast institution has greater poverty, greater ethnic/racial diversity, and lower education levels. Survey questions included: age, smoking history, lung cancer screening knowledge, adherence, and interest. Lung cancer screening eligibility was determined for both 2013 and 2021 USPSTF guidelines. Descriptive statistics were calculated and data were compared between groups using the chi-square test, Mann-Whitney non-parametric test, and the two-sample t-test.
RESULTS: 5512 surveys were completed; 33% (1824) of women reported a history of smoking- 30% (1656) former smokers and 3% (156) current smokers. Among women with a smoking history, 7% (127/1824) were eligible for lung cancer screening using 2013 and 11% (207/1824) using the 2021 USPSTF criteria. Interest in lung cancer screening was high (73%; 151/ 207) among eligible women using 2021 USPSTF criteria, but only 42% (87/207) had heard of lung cancer screening and only 28% (57/207) had received prior LDCT screening.
CONCLUSION: Eligible screening mammography patients reported high levels of interest in lung cancer screening but low levels of knowledge and adherence. Linking mammography and LDCT appointments may improve lung cancer screening adherence.